Comparative Immunization Study Using RNA and DNA Constructs Encoding a Part of the Plasmodium falciparum Antigen Pf332

Development of nucleic acid‐based vaccines against parasitic diseases shows great promise, although certain concerns about safety aspects of conventional DNA vaccines have been raised. This study presents a comparison of antibody responses induced in mice by DNA and RNA‐based immunization with vectors encoding a part of the P. falciparum antigen Pf332. Two types of plasmids were used, one conventional DNA plasmid containing a cytomegalovirus promoter and one suicidal DNA plasmid encoding the Semliki Forest virus (SFV) replicase. RNA, encoding the SFV replicase and the relevant antigen, was delivered either as naked RNA or packaged in SFV suicide particles. In general, the antibody responses induced by the DNA plasmids were low and peaking after three injections, the conventional plasmid giving the highest responses. Also the RNA delivered in SFV particles consistently induced antibody responses, although comparatively low. Analyses of the ratio of immunoglobulin (Ig)G1/IgG2a subclasses in the responses indicated that all plasmids resulted in a bias for a Th2‐type of response, while the SFV‐particles elicited a Th1 type of response. Importantly, all these immunogens induced an immunological memory, which could be efficiently activated by a booster injection with the corresponding protein, with unchanged patterns of IgG subclasses.

[1]  M. A. Liu,et al.  DNA vaccines: a review , 2003, Journal of internal medicine.

[2]  M. Hansson,et al.  Mammalian cell production of a respiratory syncytial virus (RSV) candidate vaccine recovered using a product‐specific affinity column , 2001, Biotechnology and applied biochemistry.

[3]  S. Ståhl,et al.  Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen. , 2000, FEMS immunology and medical microbiology.

[4]  J. Maguire,et al.  Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. , 2000, Vaccine.

[5]  G. Atkins,et al.  Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. , 2000, The Journal of general virology.

[6]  W G Hol,et al.  International Journal for Parasitology 30 (2000) 113±118 Rapid communication , 2000 .

[7]  N. Restifo,et al.  DNA and RNA-based vaccines: principles, progress and prospects. , 1999, Vaccine.

[8]  T. Horii,et al.  Immune Responses Induced by Gene Gun or Intramuscular Injection of DNA Vaccines That Express Immunogenic Regions of the Serine Repeat Antigen from Plasmodium falciparum , 1999, Infection and Immunity.

[9]  R. Anders,et al.  The Malaria Antigens , 1999 .

[10]  A. Siddique,et al.  Inhibition of in vitro growth of Plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332 , 1999, Parasite immunology.

[11]  Haddad,et al.  Characterization of Antibody Responses to a Plasmodium falciparum Blood‐Stage Antigen Induced by a DNA Prime/Protein Boost Immunization Protocol , 1999, Scandinavian journal of immunology.

[12]  E. Gould,et al.  Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. , 1999, The Journal of general virology.

[13]  B. Wahrén,et al.  Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. , 1999, Vaccine.

[14]  J. Miyazaki,et al.  DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid. , 1999, Parasitology international.

[15]  M. Uhlén,et al.  Truncated fragments in polymerase chain reaction‐based DNA sequencing , 1999, Electrophoresis.

[16]  P. Liljeström,et al.  Two-Helper RNA System for Production of Recombinant Semliki Forest Virus Particles , 1999, Journal of Virology.

[17]  P. Liljeström,et al.  Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. , 1999, Vaccine.

[18]  L. Babiuk,et al.  DNA vaccines: a review. , 1999, Advances in virus research.

[19]  S. Brunet,et al.  Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. , 1998, AIDS research and human retroviruses.

[20]  S. Hoffman,et al.  Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Liljeström,et al.  Enhancing immune responses using suicidal DNA vaccines , 1998, Nature Biotechnology.

[22]  S. Ståhl,et al.  Differential induction of immunoglobulin G subclasses by immunization with DNA vectors containing or lacking a signal sequence. , 1998, Immunology letters.

[23]  Marion Becker,et al.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.

[24]  J. Wiesner,et al.  Biology of giant proteins of Plasmodium: resolution on polyacrylamide-agarose composite gels. , 1998, Parasitology today.

[25]  P. Liljeström,et al.  Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. , 1997, AIDS research and human retroviruses.

[26]  S. Ståhl,et al.  Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice. , 1997, FEMS immunology and medical microbiology.

[27]  L. Babiuk,et al.  Polynucleotide vaccines in animals: enhancing and modulating responses. , 1997, Vaccine.

[28]  F. Sterky,et al.  Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332. , 1997, Molecular immunology.

[29]  R. Buckland,et al.  Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. , 1996, Virology.

[30]  S. Ståhl,et al.  Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA. , 1996, Experimental parasitology.

[31]  M. Uhlén,et al.  Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum‐reactive antibodies which inhibit parasite growth but not cytoadherence , 1995, Parasite immunology.

[32]  G. Rhodes,et al.  Self-replicating Semliki Forest virus RNA as recombinant vaccine. , 1994, Vaccine.

[33]  J. Mazié,et al.  Plasmodium falciparum: the Pf332 antigen is secreted from the parasite by a brefeldin A-dependent pathway and is translocated to the erythrocyte membrane via the Maurer's clefts. , 1994, Experimental parasitology.

[34]  G. Atkins,et al.  Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant Particles , 1993, Bio/Technology.

[35]  P. Perlmann,et al.  Epitope specificity and capacity to inhibit parasite growth in vitro of human antibodies to repeat sequences of the Plasmodium falciparum antigen Ag332 , 1993, Parasite immunology.

[36]  A. Scherf,et al.  Pfl I-I and Pf332: two giant proteins synthesized in erythrocytes infected with Plasmodium falciparum. , 1992, Parasitology today.

[37]  A. Scherf,et al.  The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes. , 1992, Gene.

[38]  P. Liljeström,et al.  A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon , 1991, Bio/Technology.

[39]  N. Haigwood,et al.  Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. , 1991, Nucleic acids research.

[40]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[41]  M. Wahlgren,et al.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum , 1984, The Journal of experimental medicine.

[42]  U. Rüther.  pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts. , 1982, Nucleic acids research.

[43]  J. Vieira,et al.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. , 1982, Gene.